Pulsed-Field Ablation Forum-1 Carto Innovation
|
08:00-10:00 308 |
|---|
| 主席 Chairmen | 林加锋 Jiafeng LIN, 樊友启 Youqi FAN | ||
| 主持 Moderators | 潘永康 Yongkang PAN, 郑武扬 Wuyang ZHENG, 夏淑东 Shudong XIA, 葛卫力 Weili GE, 王亚萍 Yaping WANG | ||
|
08:00-08:20 |
PFA的现在与未来 Present and Future of PFA |
刘少稳 Shaowen LIU | |
|
08:20-08:40 |
绿色PFA手术流程和技术要点 Green PFA Workflow and Technical Key Points |
蒋晨阳 Chenyang JIANG | |
|
08:40-09:00 |
PFA房颤消融临床实践与再认识 PFA Ablation for Atrial FibrillationClinical Practice and Reappraisal |
李强 Qiang LI | |
|
09:00-09:20 |
房颤脉冲消融并发症的预防与处理 Prevention and Management of Complications in PFA for Atrial Fibrillation |
常栋 Dong CHANG | |
|
09:20-09:40 |
高效三维脉冲消融流程和价值分享 3D Mapping in Pulsed Field Ablation — Efficient Workflow and Value Insights |
张必祺 Biqi ZHANG | |
|
09:40-10:00 |
脉冲场在持续性房颤中的应用 The Application of PFA in Persistent Atrial Fibrillation |
肖方毅 Fangyi XIAO | |
Cardio-Renal Forum-4
|
10:00-12:00 308 |
|---|
| 主席 Chairmen | 蒋峻 Jun JIANG, 毛威 Wei MAO | ||
| 主持 Moderators | 叶红华 Honghua YE, 吴连拼 Lianpin WU, 张邢炜 Xingwei ZHANG, 胡惠林 Huilin HU | ||
| 讨论嘉宾 Discussants | 何文明 Wenming HE, 米亚非 Yafei MI, 姚俊龙 Junlong YAO, 曹建成 Jiancheng CAO | ||
|
10:00-10:05 |
开场 Opening Remarks |
蒋峻 Jun JIANG | |
|
10:05-10:25 |
2025ESC/EAS血脂管理指南更新要点解读 Key Updates in the 2025 ESC/EAS Guidelines for Lipid Management |
何奔 Ben HE | |
|
10:25-10:45 |
回顾源头，筑就经典——从斑块认知变迁看他汀在逆转斑块中的基石地位 Revisiting the Origin, Building a Classic: The Cornerstone Role of Statins in Plaque Regression from the Perspective of Evolving Plaque Understanding |
陈桢玥 Zhenyue CHEN | |
|
10:45-11:05 |
CKM管理，没“他”不行——论他汀在心血管代谢疾病防治中的基石地位 CKM Management: The Indispensable Role of Statins in Preventing and Managing Cardiometabolic Diseases |
彭道泉 Daoquan PENG | |
|
11:05-11:25 |
他汀护心，兼顾安全——他汀降脂治疗中如何权衡肝脏风险 Statin Cardioprotection with Safety Considerations: Balancing Liver Risks in Lipid-Lowering Therapy |
茅益民 Yimin MAO | |
|
11:25-11:45 |
PCSK9i应答不良病例一例：对于以他汀为基础的标准化降脂方案的探讨 A Case of Poor Response to PCSK9 Inhibitors: Discussion on Standardized Statin-Based Lipid-Lowering Strategies |
苏立杰 Lijie SU | |
|
11:45-12:00 |
讨论&总结 Discussion & Remarks |
||
Pulsed-Field Ablation Forum-2
|
13:30-15:30 308 |
|---|
| 主持 Moderators | 夏云龙 Yunlong XIA, 张必祺 Biqi ZHANG, 郁一波 Yibo YU | ||
|
13:30-13:50 |
PFA在持续性房颤中的应用策略 Application Strategy of PFA in Persistent Atrial Fibrillation |
徐娟 Juan XU | |
|
13:50-14:10 |
PFA围手术期并发症预防策略及一站式单中心经验分享 Perioperative Complication Prevention Strategy of PFA and One-Stop Single-Center Experience Sharing |
燕翼 Yi YAN | |
|
14:10-14:30 |
影像融合技术与PFA手术精准化 Image Fusion Technology and Precision of PFA Surgery |
樊友启 Youqi FAN | |
|
14:30-14:50 |
三维环形导管PFA消融的初步应用体会 Initial Clinical Experience with 3D-Guided Circular Catheter for Pulsed-Field Ablation |
唐恺 Kai TANG | |
|
14:50-15:10 |
脉冲消融中精准贴靠的有效性及安全性文献解析 Analysis of Efficacy and Safety of Precise Catheter-Tissue Contact in Pulsed-field Ablation: A Literature Review |
杨剑 Jian YANG | |
|
15:10-15:30 |
讨论 Discussion |
||
Anticoagulation Symposium
|
15:30-17:30 308 |
|---|
| 主持 Moderators | 王利宏 Lihong WANG, 蒋晨阳 Chenyang JIANG, 陈治奎 Zhikui CHEN, 李杨玲 Yangling LI, 方崇峰 Chongfeng FANG | ||
|
15:30-15:50 |
全球血栓管理循证与实践新进展 Global New Advances in Evidence-Based Practice of Thrombosis Management |
刘少稳 Shaowen LIU | |
|
15:50-16:10 |
房颤导管消融围术期的抗凝优化管理策略 Optimized Anticoagulation Management in the Perioperative Period of Atrial Fibrillation Catheter Ablation |
夏淑东 Shudong XIA | |
|
16:10-16:30 |
浙江抗凝药师管理联盟分享 Sharing of Zhejiang Anticoagulant Pharmacist Management Alliance |
徐慧敏 Huimin XU | |
|
16:30-16:50 |
房颤合并冠心病患者优选的抗栓方案 The Preferred Antithrombotic Regimen for Patients with Atrial Fibrillation Combined with Coronary Heart Disease |
潘轶斌 Yibin PAN | |
|
16:50-17:10 |
深度解读中国房颤管理指南（2025) In-Depth Interpretation of the Chinese Guidelines for the Management of Atrial Fibrillation (2025) |
陈晓敏 Xiaomin CHEN | |
|
17:10-17:30 |
讨论 Discussion |
||